首页 正文

Prevalent-New User Design for Biosimilar Safety Using Saudi Real-World Data

{{output}}
Objective: Incidents of infections associated with biosimilar biological disease-modifying antirheumatic drugs (bDMARDs) have been communicated to the Saudi Food and Drug Authority (SFDA). This study aimed to evaluate the infecti... ...